Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bioatla, Inc. (BCAB)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 46,110,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   BioAtla is a biopharmaceutical company engaged in developing specific and selective antibody-based therapeutics for the treatment of various cancers. Co.'s lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. Co. also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 81,495 83,495 252,735
Total Buy Value $0 $172,540 $177,620 $814,041
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 5 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 133
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Short Jay M Phd Chief Executive Officer   •       •       •   2023-03-29 4 B $2.47 $100,862 D/D 40,800 1,412,387 3.23     -
   Mcbrinn Sylvia Director   –       •      –    2023-03-28 4 B $2.35 $9,400 D/D 4,000 19,125 2.39     -
   Vasquez Christian See Remarks   •       –      –    2023-03-28 4 B $2.40 $47,970 D/D 20,000 102,709 2.74     -
   Vasquez Christian See Remarks   •       –      –    2023-02-28 4 D $2.98 $682 D/D (229) 82,709     -
   Waldron Richard A Chief Financial Officer   •       –      –    2023-02-28 4 D $2.98 $2,891 D/D (970) 129,660     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2023-02-28 4 D $2.89 $8,346 D/D (2,888) 1,371,587     -
   Smith Scott Andrew Former President   •       •      –    2023-02-28 4 D $2.98 $5,337 D/D (1,791) 316,908     -
   Sievers Eric Chief Medical Officer   •       –      –    2023-02-28 4 D $2.98 $1,651 D/D (554) 92,746     -
   Smith Scott Andrew President   •       •      –    2023-01-31 4 D $3.79 $8,266 D/D (2,181) 318,699     -
   Sievers Eric Chief Medical Officer   •       –      –    2023-01-31 4 D $3.79 $2,479 D/D (654) 93,300     -
   Vasquez Christian See Remarks   •       –      –    2023-01-31 4 D $3.79 $868 D/D (229) 82,938     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2023-01-31 4 D $3.79 $13,329 D/D (3,517) 1,374,475     -
   Waldron Richard A Chief Financial Officer   •       –      –    2023-01-31 4 D $3.79 $4,336 D/D (1,144) 130,630     -
   Vasquez Christian See Remarks   •       –      –    2022-12-31 4 D $8.25 $1,601 D/D (194) 83,167     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-12-31 4 D $8.25 $38,503 D/D (4,667) 1,377,992     -
   Smith Scott Andrew President   •       •      –    2022-12-31 4 D $8.25 $14,776 D/D (1,791) 320,880     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-12-31 4 D $8.25 $4,571 D/D (554) 93,954     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-12-31 4 D $8.25 $8,003 D/D (970) 131,774     -
   Mcbrinn Sylvia Director   –       •      –    2022-12-19 4 B $8.33 $30,813 D/D 3,700 9,125 2.39     -
   Vasquez Christian See Remarks   •       –      –    2022-11-30 4 D $11.01 $2,136 D/D (194) 83,361     -
   Smith Scott Andrew President   •       •      –    2022-11-30 4 D $11.01 $19,719 D/D (1,791) 322,671     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-11-30 4 D $11.01 $10,680 D/D (970) 132,744     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-11-30 4 D $11.01 $6,111 D/D (555) 94,508     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-11-30 4 D $11.01 $51,384 D/D (4,667) 1,382,659     -
   Mcbrinn Sylvia Director   –       •      –    2022-11-22 4 B $8.27 $16,540 D/D 2,000 5,425 2.39     -
  133 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us